HTT, ATXN1 and ATXN2 CAG triplet repeat sizes: exploring their role in the disease risk and cancer comorbidity in Parkinson's disease

被引:0
|
作者
Perez-Oliveira, Sergio [1 ,2 ]
Alvarez, Ignacio [3 ,4 ]
Menendez-Gonzalez, Manuel [2 ,5 ]
Duarte-Herrera, Israel David [2 ,7 ]
Blazquez-Estrada, Marta [2 ,5 ,6 ]
Castilla-Silgado, Juan [8 ]
Suarez, Esther [2 ,5 ]
Garcia-Fernandez, Ciara [2 ,5 ]
Siso-Garcia, Pablo [2 ,9 ]
Garcia-Gonzalez, Pablo [10 ]
Rosende-Roca, Maitee [10 ,11 ]
Boada, Merce [10 ,11 ]
Ruiz, Agustin [10 ,11 ]
Infante, Jon [11 ,12 ]
de la Casa-fages, Beatriz [13 ,14 ]
Gonzalez-Aramburu, Isabel [11 ,12 ]
Alvarez, Victoria [1 ,2 ]
Pastor, Pau [15 ,16 ]
机构
[1] Hosp Univ Cent Asturias, Lab Genet, Oviedo 33011, Spain
[2] Inst Invest Sanit Principado Asturias ISPA, Oviedo 33011, Spain
[3] Univ Hosp Mutua Terrassa, Movement Disorders Unit, Dept Neurol, Barcelona 08221, Spain
[4] Fundacio Docencia & Recerca Mutua Terrassa, Terrassa 08221, Barcelona, Spain
[5] Hosp Univ Cent Asturias, Serv Neurol, Oviedo 33011, Spain
[6] Univ Oviedo, Dept Med, Oviedo 33006, Spain
[7] Networked Biomed Res Ctr CIBER Resp Dis, Madrid 28029, Spain
[8] Asociac Parkinson Asturias APARKAS, Oviedo 33011, Spain
[9] Hosp Univ Cabuenes, Serv Neurol, Gijon 33394, Spain
[10] Univ Int Catalunya, Ace Alzheimer Ctr Barcelona, Barcelona 08028, Spain
[11] Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIBERNED, Madrid 28029, Spain
[12] Univ Cantabria, Marques Valdecilla Univ Hosp, Dept Neurol, Santander 39008, Spain
[13] Hosp Gen Univ Gregorio Maranon, Dept Neurol, Movement Disorders Unit, Madrid 28007, Spain
[14] Inst Invest Sanit Gregorio Maranon, Madrid 28007, Spain
[15] Univ Hosp Germans Trias & Pujol, Dept Neurol, Unit Neurodegenerat Dis, Barcelona 08916, Spain
[16] Germans Trias & Pujol Res Inst IGTP Badalona, Barcelona 08916, Spain
关键词
Parkinson's disease; cancer; CAG repeats; TUMOR-SUPPRESSOR GENE; ASSOCIATION; PREVALENCE;
D O I
10.1093/braincomms/fcaf060
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease genetic embraces genetic and non-genetic factors. It has been suggested a link between CAG repeat number in the HTT, ATXN1 and ATXN2 genes and different neurodegenerative diseases. Several genetic factors involved in Parkinson's disease development are indeed associated with cancer pathways. Moreover, several studies found a low prevalence of cancer in neurodegenerative diseases that can be associated with a low CAG repeat size in several genes. This study aimed to investigate the influence of CAG repeat sizes in ATXN1, ATXN2 and HTT genes on the risk for developing cancer and Parkinson's disease in a large cohort of patients with idiopathic Parkinson's disease and healthy controls. The work included 1052 patients with idiopathic Parkinson's disease and 1070 controls of European ancestry. CAG repeat sizes in HTT, ATXN1 and ATXN2 genes were analysed. Dunn's multiple comparison test for quantitative variables and logistic and linear regression were used. The long ATXN1 and HTT alleles and CAG size and both the ATXN2 short and long alleles were predictors for the Parkinson's disease risk. The long CAG ATXN1 allele gene was associated with the risk of cancer. No association was observed between CAG size in the HTT and ATXN2 genes and risk of cancer in patients with Parkinson's disease. We described an association of HTT, ATXN1 and ATXN2 with the risk of Parkinson's disease, which reinforce the hypothesis of the common pathway of neurodegeneration. Besides, ATXN1 could be a predictor of cancer risk among patients with Parkinson's disease, and these results suggest that cancer and neurodegeneration processes can share common pathways. P & eacute;rez-Oliveira et al. reported association between CAG repeat expansion disorders and the risk of Parkinson disease and also investigated the connection between CAG repeats and cancer comorbidity in patients with Parkinson's disease. ATXN1 could be a predictor of cancer risk among patients with Parkinson's disease, suggesting that cancer and neurodegeneration process can share common pathways.
引用
收藏
页数:12
相关论文
共 12 条
  • [1] HTT, ATXN1 and ATXN2 CAG repeat size and risk for cancer and Parkinson disease.
    Perez Oliveira, Sergio
    Alvarez Fernandez, Ignacio
    Menendez-Gonzalez, Manuel
    David Duarte-Herrera, Israel
    Blazquez-Estrada, Marta
    Suarez, Esther
    Garcia-Fernandez, Ciara
    Siso-Garcia, Pablo
    Garcia-Gonzalez, Pablo
    Rosende-Roca, Maitee
    Boada, Merce
    Ruiz, Agustin
    Infante, Jon
    De la Casa Fages, Beatriz
    Gonzalez-Aramburu, Isabel
    Alvarez Martinez, Maria Victoria
    Pastor, Pau
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1474 - 1474
  • [2] Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease
    Rosas, Irene
    Martinez, Carmen
    Clarimon, Jordi
    Lleo, Alberto
    Illan-Gala, Ignacio
    Dols-Icardo, Oriol
    Borroni, Barbara
    Almeida, Maria Rosario
    van der Zee, Julie
    Van Broeckhoven, Christine
    Bruni, Amalia C.
    Anfossi, Maria
    Bernardi, Livia
    Maletta, Raffaele
    Serpente, Maria
    Galimberti, Daniela
    Scarpini, Elio
    Rossi, Giacomina
    Caroppo, Paola
    Benussi, Luisa
    Ghidoni, Roberta
    Binetti, Giuliano
    Nacmias, Benedetta
    Sorbi, Sandro
    Piaceri, Irene
    Bagnoli, Silvia
    Antonell, Anna
    Sanchez-Valle, Raquel
    De la Casa-Fages, Beatriz
    Grandas, Francisco
    Diez-Fairen, Monica
    Pastor, Pau
    Ferrari, Raffaele
    Alvarez, Victoria
    Menendez-Gonzalez, Manuel
    NEUROBIOLOGY OF AGING, 2020, 87 : 139.e1 - 139.e7
  • [3] Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project
    Akcimen, Fulya
    Ross, Jay P.
    Liao, Calwing
    Spiegelman, Dan
    Dion, Patrick A.
    Rouleau, Guy A.
    MOVEMENT DISORDERS, 2021, 36 (02) : 514 - 518
  • [4] Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis
    Novy, Camilla
    Busk, Oyvind L.
    Tysnes, Ole-Bjorn
    Landa, Sigve S.
    Aanjesen, Tori N.
    Alstadhaug, Karl B.
    Bjerknes, Tale L.
    Bjorna, Ingrid K.
    Brathen, Geir
    Dahl, Elin
    Demic, Natasha
    Fahlstrom, Maria
    Flemmen, Heidi O.
    Hallerstig, Erika
    HogenEsch, Ineke
    Kampman, Margitta T.
    Kleveland, Grethe
    Kvernmo, Helene B.
    Ljostad, Unn
    Maniaol, Angelina
    Morsund, Aase Hagen
    Nakken, Ola
    Olsen, Cathrine G.
    Schluter, Katrin
    Utvik, May-Sissel
    Yaseen, Ryaz
    Holla, Oystein L.
    Holmoy, Trygve
    Hoyer, Helle
    BRAIN COMMUNICATIONS, 2024, 6 (02)
  • [5] Association of Long ATXN2 CAG Repeat Sizes With Increased Risk of Amyotrophic Lateral Sclerosis
    Daoud, Hussein
    Belzil, Veronique
    Martins, Sandra
    Sabbagh, Mike
    Provencher, Pierre
    Lacomblez, Lucette
    Meininger, Vincent
    Camu, William
    Dupre, Nicolas
    Dion, Patrick A.
    Rouleau, Guy A.
    ARCHIVES OF NEUROLOGY, 2011, 68 (06) : 739 - 742
  • [6] Mutations in the LRRK2 and Parkin genes and intermediate alleles in the HTT and ATXN1 genes modulate the risk of cancer in Parkinson's disease
    Rosas, I.
    Cuesta Llavona, E.
    Garcia Siso, P.
    Garcia-Fernandez, C.
    Suarez San Martin, E.
    Blazquez, M.
    Moris, G.
    Alvarez, V.
    Menendez Gonzalez, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 233 - 233
  • [7] Repeat length variations in ATXN1 and AR modify disease expression in Alzheimer's disease
    Gardiner, Sarah L.
    Harder, Aster V. E.
    Campman, Yvonne J. M.
    Trompet, Stella
    Gussekloo, Jacobijn
    van Belzen, Martine J.
    Boogaare, Merel W.
    Roos, Raymund A. C.
    Jansen, Iris E.
    Pijnenburg, Yolande A. L.
    Scheltens, Philip
    van der Flier, Wiesje M.
    Aziz, N. Ahmad
    NEUROBIOLOGY OF AGING, 2019, 73 : 230.e9 - 230.e17
  • [8] Intermediate expansions in ataxia genes, ATXN2 and FMR1, associated with Parkinson's disease
    Abramycheva, N.
    Fedotova, E.
    Stepanova, M.
    Moroz, A.
    Klyushnikov, S.
    Illarioshkin, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 257 - 257
  • [9] Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington's Disease
    Keo, Arlin
    Aziz, N. Ahmad
    Dzyubachyk, Oleh
    van der Grond, Jeroen
    van Roon-Mom, Willeke M. C.
    Lelieveldt, Boudewijn P. F.
    Reinders, Marcel J. T.
    Mahfouz, Ahmed
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2017, 10
  • [10] THE ROLE OF FAN1 IN HTT CAG REPEAT INSTABILITY AND AGE AT ONSET IN THE R6/1 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Fears, Kyle
    Binda, Caroline
    Miles, Elin
    Massey, Thomas
    Jones, Lesley
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A18 - A18